Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| FRACTYL HEALTH, INC.GUTS · Entity 6700 | Director · Chief Executive Officer | June 10, 2026 | June 11, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
FRACTYL HEALTH, INC.
Report date June 10, 2026 · Filed June 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 540,557 |
Reported balance
After 2026-06-10 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-06-10 · Purchase · Acquired 25,000 · Balance 540,557 F1: Open market purchase. F2: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.7213 to $0.7324, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F3: Includes 13,812 shares of common stock purchased pursuant to the Issuer's 2024 Employee Stock Purchase Plan (ESPP) on January 30, 2026, at a purchase price of $0.391 per share. |
| Common StockSEC Table I · non-derivative | IndirectBy 2021 Irrevocable Trust | 292,171 |
Reported balance
Holding disclosure · report date 2026-06-10 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 292,171 |
| Common StockSEC Table I · non-derivative | IndirectBy 2016 Irrevocable Trust | 292,170 |
Reported balance
Holding disclosure · report date 2026-06-10 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 292,170 |
| Common StockSEC Table I · non-derivative | IndirectBy 2021 Family Trust | 18,639 |
Reported balance
Holding disclosure · report date 2026-06-10 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 18,639 |
Filing footnotes · ownership attribution and instrument terms
F1: Open market purchase.
F2: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.7213 to $0.7324, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F3: Includes 13,812 shares of common stock purchased pursuant to the Issuer's 2024 Employee Stock Purchase Plan (ESPP) on January 30, 2026, at a purchase price of $0.391 per share.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 10, 2026 Filed Jun 11, 2026 20:59 UTC | FRACTYL HEALTH, INC. GUTS · Entity 6700 | PurchaseCommon Stock | 25,000 | $0.73 | $18,252.50 |
DisclosureSEC source: 0001193125-26-267833 · ownership.xml · nonDerivative · entry 1 Rajagopalan Harith · CIK 0001667672 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 540,557 F1 · kind: Open market purchase. F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.7213 to $0.7324, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F3 · balance_after: Includes 13,812 shares of common stock purchased pursuant to the Issuer's 2024 Employee Stock Purchase Plan (ESPP) on January 30, 2026, at a purchase price of $0.391 per share. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 23:00 UTC | FRACTYL HEALTH, INC. GUTS · Entity 6700 | GrantStock Option (right to buy) · Derivative | 2,486,302 | $0.00 Strike: $2.24 | $0.00 |
DisclosureSEC source: 0001193125-25-323017 · ownership.xml · derivative · entry 1 Rajagopalan Harith · CIK 0001667672 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,486,302 Underlying: Common Stock · 2,486,302 shares Expires 2035-12-14 F1 · derivative.exercise_date: The stock option vests and becomes exercisable in equal installments on each of the first three anniversaries of the grant date, subject to the Reporting Persons's continuing in employment through each such vesting date. Read SEC document |
| December 04, 2025 Filed Dec 8, 2025 12:05 UTC | FRACTYL HEALTH, INC. GUTS · Entity 6700 | PurchaseCommon Stock | 10,416 | $1.92 | $19,998.72 |
DisclosureSEC source: 0001193125-25-310558 · ownership.xml · nonDerivative · entry 1 Rajagopalan Harith · CIK 0001667672 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 501,745 F1 · shares: The shares of Common Stock were purchased by the Reporting Person from the Issuer in a private placement, which transaction is exempt from Section 16(b) in accordance with Rule 16b-3(d)(1) promulgated under the Securities Exchange Act of 1934, as amended. Read SEC document |
| February 27, 2025 Filed Mar 4, 2025 01:59 UTC | FRACTYL HEALTH, INC. GUTS · Entity 6700 | GrantStock Option (right to buy) · Derivative | 261,540 | $0.00 Strike: $15.00 | $0.00 |
DisclosureSEC source: 0000950170-25-031260 · ownership.xml · derivative · entry 2 Rajagopalan Harith · CIK 0001667672 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 261,540 Underlying: Common Stock · 261,540 shares Expires 2034-01-31 F2 · derivative.exercise_date: In connection with the Issuer's initial public offering, on February 1, 2024 the Reporting Person was granted, subject to the satisfaction of certain performance criteria, an option to purchase 435,900 shares of common stock to vest in the form of shares of the Issuer's common stock in four substantially equal installments on December 31, 2024 and each of the first three anniversaries thereof. On February 27, 2025, the Issuer's administrator determined that the performance criteria were partially met, resulting in 261,540 shares subject to such option being earned, of which 25% vested on December 31, 2024 and the remaining 75% will vest in substantially equal installments on the first three anniversaries thereof. Read SEC document |
| February 27, 2025 Filed Mar 4, 2025 01:59 UTC | FRACTYL HEALTH, INC. GUTS · Entity 6700 | GrantStock Option (right to buy) · Derivative | 571,491 | $0.00 Strike: $1.46 | $0.00 |
DisclosureSEC source: 0000950170-25-031260 · ownership.xml · derivative · entry 1 Rajagopalan Harith · CIK 0001667672 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 571,491 Underlying: Common Stock · 571,491 shares Expires 2035-02-26 F1 · derivative.exercise_date: The stock option vests and becomes exercisable in equal installments on each of the first four anniversaries of the grant date, subject to the Reporting Persons's continuing in employment through each such vesting date. Read SEC document |
| January 31, 2025 Filed Feb 3, 2025 23:04 UTC | FRACTYL HEALTH, INC. GUTS · Entity 6700 | Exercise / conversionStock Option · Derivative | 90,972 | $0.00 Strike: $1.70 | $0.00 |
DisclosureSEC source: 0000950170-25-012531 · ownership.xml · derivative · entry 9 Rajagopalan Harith · CIK 0001667672 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,564 Underlying: Common Stock · 90,972 shares Expires 2025-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| January 31, 2025 Filed Feb 3, 2025 23:04 UTC | FRACTYL HEALTH, INC. GUTS · Entity 6700 | SaleCommon Stock | 90,972 | $1.82 | $165,205.15 |
DisclosureSEC source: 0000950170-25-012531 · ownership.xml · nonDerivative · entry 4 Rajagopalan Harith · CIK 0001667672 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 491,329 F1 · kind: Represents sales pursuant to a Rule 10b5-1 plan that the Reporting Person entered into on September 12, 2024. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.8000 to $1.8800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 31, 2025 Filed Feb 3, 2025 23:04 UTC | FRACTYL HEALTH, INC. GUTS · Entity 6700 | Exercise / conversionCommon Stock | 90,972 | $1.70 | $154,652.40 |
DisclosureSEC source: 0000950170-25-012531 · ownership.xml · nonDerivative · entry 3 Rajagopalan Harith · CIK 0001667672 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 582,301 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 30, 2025 Filed Feb 3, 2025 23:04 UTC | FRACTYL HEALTH, INC. GUTS · Entity 6700 | Exercise / conversionStock Option · Derivative | 20,948 | $0.00 Strike: $1.70 | $0.00 |
DisclosureSEC source: 0000950170-25-012531 · ownership.xml · derivative · entry 8 Rajagopalan Harith · CIK 0001667672 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 102,536 Underlying: Common Stock · 20,948 shares Expires 2025-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| January 30, 2025 Filed Feb 3, 2025 23:04 UTC | FRACTYL HEALTH, INC. GUTS · Entity 6700 | SaleCommon Stock | 20,948 | $1.95 | $40,798.32 |
DisclosureSEC source: 0000950170-25-012531 · ownership.xml · nonDerivative · entry 2 Rajagopalan Harith · CIK 0001667672 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 491,329 F1 · kind: Represents sales pursuant to a Rule 10b5-1 plan that the Reporting Person entered into on September 12, 2024. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.9100 to $2.0400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 30, 2025 Filed Feb 3, 2025 23:04 UTC | FRACTYL HEALTH, INC. GUTS · Entity 6700 | Exercise / conversionCommon Stock | 20,948 | $1.70 | $35,611.60 |
DisclosureSEC source: 0000950170-25-012531 · ownership.xml · nonDerivative · entry 1 Rajagopalan Harith · CIK 0001667672 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 512,277 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 11, 2024 Filed Nov 13, 2024 23:26 UTC | FRACTYL HEALTH, INC. GUTS · Entity 6700 | SaleCommon Stock | 96,517 | $2.47 | $238,358.38 |
DisclosureSEC source: 0000950170-24-126560 · ownership.xml · nonDerivative · entry 2 Rajagopalan Harith · CIK 0001667672 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 491,329 F2 · kind: Represents shares sold for tax-withholding purposes due upon the vesting of the restricted stock units. Read SEC document |
| November 10, 2024 Filed Nov 13, 2024 23:26 UTC | FRACTYL HEALTH, INC. GUTS · Entity 6700 | Exercise / conversionRestricted Stock Units · Derivative | 216,924 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-126560 · ownership.xml · derivative · entry 6 Rajagopalan Harith · CIK 0001667672 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 216,924 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vested in full on November 10, 2024 and have no expiration date. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vested in full on November 10, 2024 and have no expiration date. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vested in full on November 10, 2024 and have no expiration date. Read SEC document |
| November 10, 2024 Filed Nov 13, 2024 23:26 UTC | FRACTYL HEALTH, INC. GUTS · Entity 6700 | Exercise / conversionCommon Stock | 216,924 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-126560 · ownership.xml · nonDerivative · entry 1 Rajagopalan Harith · CIK 0001667672 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 587,846 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vested in full on November 10, 2024 and have no expiration date. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 21:37 UTC | FRACTYL HEALTH, INC. GUTS · Entity 6700 | ConversionSeries A Preferred Stock · Derivative | 6,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-012835 · ownership.xml · derivative · entry 5 Rajagopalan Harith · CIK 0001667672 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By 2016 Irrevocable Trust Disclosed balance after: 0 Underlying: Common Stock · 2,795 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock. F1 · price: In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock. F1 · derivative.exercise_date: In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock. F1 · derivative.expiration_date: In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 21:37 UTC | FRACTYL HEALTH, INC. GUTS · Entity 6700 | ConversionSeries A Preferred Stock · Derivative | 14,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-012835 · ownership.xml · derivative · entry 4 Rajagopalan Harith · CIK 0001667672 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,523 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock. F1 · price: In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock. F1 · derivative.exercise_date: In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock. F1 · derivative.expiration_date: In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 21:37 UTC | FRACTYL HEALTH, INC. GUTS · Entity 6700 | ConversionCommon Stock | 2,795 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-012835 · ownership.xml · nonDerivative · entry 2 Rajagopalan Harith · CIK 0001667672 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By 2016 Irrevocable Trust Disclosed balance after: 292,170 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 21:37 UTC | FRACTYL HEALTH, INC. GUTS · Entity 6700 | ConversionCommon Stock | 6,523 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-012835 · ownership.xml · nonDerivative · entry 1 Rajagopalan Harith · CIK 0001667672 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 663,093 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.